Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Amortizatization of Intangibles: 2016-2024

Historic Amortizatization of Intangibles for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $165.3 million.

  • Collegium Pharmaceutical's Amortizatization of Intangibles rose 35.96% to $55.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.9 million, marking a year-over-year increase of 53.72%. This contributed to the annual value of $165.3 million for FY2024, which is 13.41% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Amortizatization of Intangibles stood at $165.3 million for FY2024, which was up 13.41% from $145.8 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Amortizatization of Intangibles ranged from a high of $165.3 million in FY2024 and a low of $60.7 million during FY2020.
  • Its 3-year average for Amortizatization of Intangibles is $149.1 million, with a median of $145.8 million in 2023.
  • Data for Collegium Pharmaceutical's Amortizatization of Intangibles shows a peak YoY skyrocketed of 311.33% (in 2020) over the last 5 years.
  • Collegium Pharmaceutical's Amortizatization of Intangibles (Yearly) stood at $60.7 million in 2020, then increased by 10.71% to $67.2 million in 2021, then surged by 102.82% to $136.3 million in 2022, then climbed by 6.98% to $145.8 million in 2023, then grew by 13.41% to $165.3 million in 2024.